Kenneth L. Waggoner

Overview

Kenneth L. Waggoner received an average of $659K in total compensation, including $584K in salary, at PharmaCyte Biotech from 2021 to 2023.

Source: SEC filings on March 27, 2024 and November 25, 2022.

Related executives

We found three more executives who work or worked at PharmaCyte Biotech.

Carlos Trujillo

PharmaCyte Biotech

Chief Financial Officer

Joshua Silverman

PharmaCyte Biotech

Chief Executive Officer

Gerald Crabtree

PharmaCyte Biotech

Chief Scientific Officer

News

You may also like